Literature DB >> 30422726

Computational investigation of mechanistic insights of Aβ42 interactions against extracellular domain of nAChRα7 in Alzheimer's disease.

Mubashir Hassan1, Saba Shahzadi2,3, Hussain Raza1, Muhammad Athar Abbasi1,4, Hany Alashwal5, Nazar Zaki5, Ahmed A Moustafa6,7,8, Sung-Yum Seo1.   

Abstract

AIM: Amyloid beta (Aβ) 1-42, which is a basic constituent of amyloid plaques, binds with extracellular transmembrane receptor nicotine acetylcholine receptor α7 (nAChRα7) in Alzheimer's disease.
MATERIALS AND METHODS: In the current study, a computational approach was employed to explore the active binding sites of nAChRα7 through Aβ 1-42 interactions and their involvement in the activation of downstream signalling pathways. Sequential and structural analyses were performed on the extracellular part of nAChRα7 to identify its core active binding site.
RESULTS: Results showed that a conserved residual pattern and well superimposed structures were observed in all nAChRs proteins. Molecular docking servers were used to predict the common interactive residues in nAChRα7 and Aβ1-42 proteins. The docking profile results showed some common interactive residues such as Glu22, Ala42 and Trp171 may consider as the active key player in the activation of downstream signalling pathways. Moreover, the signal communication and receiving efficacy of best-docked complexes was checked through DynOmic online server. Furthermore, the results from molecular dynamic simulation experiment showed the stability of nAChRα7. The generated root mean square deviations and fluctuations (RMSD/F), solvent accessible surface area (SASA) and radius of gyration (Rg) graphs of nAChRα7 also showed its backbone stability and compactness, respectively.
CONCLUSION: Taken together, our predicted results intimated the structural insight on the molecular interactions of beta amyloid protein involved in the activation of nAChRα7 receptor. In future, a better understanding of nAChRα7 and their interconnected proteins signalling cascade may be consider as target to cure Alzheimer's disease.

Entities:  

Keywords:  Alzheimer’s disease; Aβ42; computational modelling; dynamic simulation; molecular docking; nAChRα7

Mesh:

Substances:

Year:  2019        PMID: 30422726     DOI: 10.1080/00207454.2018.1543670

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  4 in total

1.  Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.

Authors:  Mubashir Hassan; Muhammad Yasir; Saba Shahzadi; Andrzej Kloczkowski
Journal:  ACS Omega       Date:  2022-06-01

2.  Mechanistic insights into TNFR1/MADD death domains in Alzheimer's disease through conformational molecular dynamic analysis.

Authors:  Mubashir Hassan; Sara Zahid; Hany Alashwal; Andrzej Kloczkowski; Ahmed A Moustafa
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

3.  Structure, Dynamics, and Ligand Recognition of Human-Specific CHRFAM7A (Dupα7) Nicotinic Receptor Linked to Neuropsychiatric Disorders.

Authors:  Danlin Liu; João V de Souza; Ayaz Ahmad; Agnieszka K Bronowska
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

4.  Lovastatin Differentially Regulates α7 and α4 Neuronal Nicotinic Acetylcholine Receptor Levels in Rat Hippocampal Neurons.

Authors:  Virginia Borroni; Constanza Kamerbeek; María F Pediconi; Francisco J Barrantes
Journal:  Molecules       Date:  2020-10-20       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.